These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 627447)

  • 41. Thalidomide in type-2 lepra reaction--a clinical experience.
    Jadhav VH; Patki AH; Mehta JM
    Indian J Lepr; 1990; 62(3):316-20. PubMed ID: 2262716
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment with thalidomide in steroid dependency and neuritis.
    Theophilus S
    Lepr India; 1980 Jul; 52(3):423-8. PubMed ID: 7206639
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Thalidomide and lepromatous leprosy reaction].
    Jonquières ED; Mosto SJ; Brusco CM
    Arch Argent Dermatol; 1967 Sep; 17(3):279-86. PubMed ID: 5596976
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical evaluation studies in lepromatous leprosy. Sixth series: effect (on lepra reaction) of supplementing DDS with dexamethasone, methandrostenolone, or mefenamic acid.
    Doull JA; Tolentino JG; Guinto RS; Rodriguez JN; Leano LM; Fernandez JV; Rivera JN; Fajardo TT
    Int J Lepr Other Mycobact Dis; 1967; 35(2):128-39. PubMed ID: 5338957
    [No Abstract]   [Full Text] [Related]  

  • 45. Iridocyclitis in lepra reaction treated with thalidomide.
    Sheskin J; Zauberman H
    Lepr Rev; 1970 Oct; 41(4):233-5. PubMed ID: 5534537
    [No Abstract]   [Full Text] [Related]  

  • 46. Lepra insidiosa.
    Simons RD
    Dermatologica; 1966; 133(4):314-6. PubMed ID: 5954343
    [No Abstract]   [Full Text] [Related]  

  • 47. Therapy of leprosy.
    Convit J; Browne SG; Languillon J; Pettit JH; Ramanujam K; Sagher F; Sheskin J; Tarabini G; de Souza Lima L; Tolentino JG; Waters MF; Bechelli LM; Martínez Domínguez V
    Bull World Health Organ; 1970; 42(5):667-72. PubMed ID: 5311056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The evaluation of present antileprosy compounds.
    Browne SG
    Adv Pharmacol (1962); 1969; 7():211-51. PubMed ID: 4190238
    [No Abstract]   [Full Text] [Related]  

  • 49. [Thalidomide in leprosy reactions].
    Netto LS
    Rev Bras Med; 1967 Sep; 24(9):760-3. PubMed ID: 5618212
    [No Abstract]   [Full Text] [Related]  

  • 50. [Experiences with thalidomide in 2 patients with acute lepromatous leprosy reactions].
    Hogerzeil LM; Simons RD
    Ned Tijdschr Geneeskd; 1966 Sep; 110(39):1722-3. PubMed ID: 5977696
    [No Abstract]   [Full Text] [Related]  

  • 51. [2 cases of anti-reactive ineffectiveness of thalidomide treatment of leprosy].
    Merklen FP; Cottenot F
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(6):738-9. PubMed ID: 5712976
    [No Abstract]   [Full Text] [Related]  

  • 52. The effects of thalidomide on leprosy reaction.
    Languillon J
    Int J Lepr Other Mycobact Dis; 1971; 39(2):590-2. PubMed ID: 4948094
    [No Abstract]   [Full Text] [Related]  

  • 53. Supplies of thalidomide for use in leprosy.
    Loretti A; Barchi E
    Lepr Rev; 1986 Mar; 57(1):76-7. PubMed ID: 3702585
    [No Abstract]   [Full Text] [Related]  

  • 54. [Leprous reaction and thalidomide. Results of treatment of 30 cases].
    Saul A
    Prensa Med Mex; 1969; 34(11):403-9. PubMed ID: 5381704
    [No Abstract]   [Full Text] [Related]  

  • 55. Unsatisfactory results with thalidomide as a specific treatment for leprosy.
    Sheskin J; Sagher F; Dorfman M; Schrader-Beielstein HW
    Isr J Med Sci; 1968; 4(4):901-4. PubMed ID: 5710961
    [No Abstract]   [Full Text] [Related]  

  • 56. Thalidomide and leprosy.
    Crawford CL
    Lancet; 1985 Aug; 2(8450):331. PubMed ID: 2862495
    [No Abstract]   [Full Text] [Related]  

  • 57. Synthesis and evaluation of novel dapsone-thalidomide hybrids for the treatment of type 2 leprosy reactions.
    Yamasaki PR; do Nascimento DC; Chelucci RC; de Faria Fernandes Belone A; Rosa PS; Diório SM; de Melo TR; Barbieri KP; Placeres MC; Carlos IZ; Chung MC; dos Santos JL
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3084-7. PubMed ID: 24907144
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Thalidomide in the treatment of leprosy reactions. 3 years of experience in Mexico].
    Latapí F; Saúl A; Gómez-Vidal M
    Gac Med Mex; 1969 Oct; 99(10):917-31. PubMed ID: 5363611
    [No Abstract]   [Full Text] [Related]  

  • 59. [Supidimide, a non-teratogenic thalidomide analog for the treatment of leprosy reaction?].
    Sheskin J; Mückter H; Frankus E
    Hautarzt; 1983 Apr; 34(4):168-70. PubMed ID: 6853166
    [No Abstract]   [Full Text] [Related]  

  • 60. [Rapidly resolutive action of thalidomide on recurrences of leprosy].
    Degos R; Lortat-Jacob E; Civatte J; Daniel F
    Bull Soc Fr Dermatol Syphiligr; 1966; 73(5):474-8. PubMed ID: 5987422
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.